简体
简体中文
繁體中文

颠覆性国会民主党交易主动型ETF NANC 深 沪

等待开盘 11-20 09:30:00 美东时间

48.20

+0.608

+1.28%

华盛通华盛通
立即下载
  • 最 高48.52
  • 今 开47.5916
  • 成交量 4875股
  • 最 低 48.20
  • 昨 收 47.5916
  • 总市值 2.72亿
  • 52周最高 53.715
  • 市盈率 静 --
  • 换手率 0.09%
  • 52周最低 40.7852
  • 委 比 0.00%
  • 总股本 565.00万
  • 历史最高 53.715
  • 量 比 0.68
  • 振 幅 0.67%
  • 历史最低 22.5698
  • 每 手 1
  • 风险率 3.05%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Primech Holdings (Nasdaq: PMEC) Announces HYTRON Showcase at BUILDING MAINTENANCE & CLEAN EXPO 2026 in Japan

    HYTRON, Primech AI's autonomous restroom-cleaning robot, is showcased at BUILDING MAINTENANCE & CLEAN EXPO 2026 in Tokyo from November 18–20, aiming to introduce its advanced cleaning capabilities to industry professionals and potential customers. This event supports Primech AI's international expansion efforts, enhancing HYTRON's visibility in Japan and fostering industry engagement. HYTRON, designed for commercial environments, automates repeti...

    11-18 13:45

  • 中期选举落地,为何AI大涨?

    今天,全球市场在几个小时里走完了一轮完整的情绪过山车。 国内这边,A股早盘低迷震荡,午后资金涌入科技主线,科创100大涨10.14%,创近两年单日最大涨幅;创业...

    11-04 19:59

  • 今天大涨原因找到了

      炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!   来源:贩财局   1)中期选举结束,共和党大败,但利空落地,全球股市开始V...

    11-04 14:14

  • Madrigal to Present Multiple Abstracts at AASLD's The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundational Therapy for MASH

    Madrigal Pharmaceuticals announced that 13 abstracts featuring Rezdiffra (resmetirom), the first approved therapy for metabolic dysfunction-associated steatohepatitis (MASH), will be presented at the AASLD Liver Meeting. The abstracts highlight real-world evidence and clinical research demonstrating Rezdiffra's effectiveness, safety, and impact on patient outcomes, including improvements in liver health biomarkers and quality of life. With data s...

    10-27 12:00